- Biotech Companies Hunt for Cash as VC Funding Dries Up Bloomberg
- How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon FierceBiotech
- Upstart Drug Companies Are Scrambling for Cash Bloomberg
- The Money Tree for Biotech Startups Loses Its Leaves Bloomberg
- View Full coverage on Google News
The wire
More investor news
Inside Startup Due Dil: the AI tool turning hours of VC diligence into 10 minutes – Tech.eu
Washburn leaves investor role at Intel Capital – Global Venturing
Fiat Ventures combines venture and advisory divisions into new brand, raises $35M Fund II – TechCrunch Venture
Ploughshare’s TAG Alliance grows to 19 members as defence spin-outs accelerate – Tech.eu
Revolut launches AI research unit to build models in-house – Sifted
Itoflow lands $2.5M to scale investment research and portfolio management – Tech.eu